The current valuation score of Barinthus Biotherapeutics PLC is 8.27, ranking 115 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.43, which is -5165.38% below the recent high of 21.96 and -1330.63% above the recent low of -6.20.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.